Hhderm Cream is a topical formulation combining Clotrimazole (1% w/w), Fusidic Acid (2% w/w), and Mometasone Furoate (0.1% w/w), designed for the effective management of mixed dermatological infections accompanied by inflammation. Clotrimazole, an imidazole antifungal agent, inhibits the biosynthesis of ergosterol, disrupting fungal cell membrane integrity and thereby treating superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. Fusidic Acid, a bacteriostatic antibiotic, targets Gram-positive bacteria by inhibiting bacterial protein synthesis through interference with elongation factor G, making it effective against Staphylococcus aureus and other susceptible strains. Mometasone Furoate, a potent topical corticosteroid, exerts anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing erythema, edema, and itching associated with inflammatory dermatoses. The combination therapy in Hhderm Cream offers a broad-spectrum approach to managing fungal and bacterial skin infections complicated by inflammation, promoting faster resolution of symptoms and preventing secondary bacterial infections. It is indicated for conditions such as infected eczema, impetiginized fungal infections, and other mixed dermatoses. Usage should be as directed by a healthcare professional, with caution advised in prolonged use or application over large areas to minimize potential corticosteroid-related adverse effects.